PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China.\', \'Institute of Pathogen Biology, Chinese Academy of Medical Science, Beijing, China.\', \'Lady Davis Institute for Medical Research, McGill University and Jewish General Hospital, Montreal, Quebec, Canada.\', \'Lady Davis Institute for Medical Research, McGill University and Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: zhenlong.liu@mail.mcgill.ca.\', \'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China. Electronic address: wangyucheng@imb.pumc.edu.cn.\', \'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China. Electronic address: shancen@imb.pumc.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(21)00199-610.1016/j.antiviral.2021.105209
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 34801588
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
?:title
  • 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34801588>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34801588>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all